NDC 60492-0249
Anthrasil
Anthrax Immune Globulin (human)
Anthrasil is a Intravenous Liquid in the Plasma Derivative category. It is labeled and distributed by Emergent Biosolutions Canada Inc.. The primary component is Anthrax Immune Globulin Human.
| Product ID | 60492-0249_3d4260fd-6286-4678-be4c-e7cf294c6434 |
| NDC | 60492-0249 |
| Product Type | Plasma Derivative |
| Proprietary Name | Anthrasil |
| Generic Name | Anthrax Immune Globulin (human) |
| Dosage Form | Liquid |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2015-10-05 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125562 |
| Labeler Name | Emergent BioSolutions Canada Inc. |
| Substance Name | ANTHRAX IMMUNE GLOBULIN HUMAN |
| Active Ingredient Strength | 60 [iU]/35mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
Packaging
NDC 60492-0249-2
7 VIAL in 1 CARTON (60492-0249-2) > 35 mL in 1 VIAL (60492-0249-1)
| Marketing Start Date | 2015-10-05 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 60492-0249-2 [60492024902]
Anthrasil LIQUID
| Marketing Category | BLA |
| Application Number | BLA125562 |
| Product Type | PLASMA DERIVATIVE |
| Marketing Start Date | 2015-10-05 |
NDC 60492-0249-1 [60492024901]
Anthrasil LIQUID
| Marketing Category | BLA |
| Application Number | BLA125562 |
| Product Type | PLASMA DERIVATIVE |
| Marketing Start Date | 2015-10-05 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| ANTHRAX IMMUNE GLOBULIN HUMAN | 60 [iU]/35mL |
Trademark Results [Anthrasil]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ANTHRASIL 86319102 5110224 Live/Registered |
EMERGENT BIOSOLUTIONS CANADA INC. 2014-06-24 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.